Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 14 of 14 entries
Sorted by: Best Match Show Resources per page
ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics.

Frontiers in genetics

Alaoui-Jamali MA, Morand GB, da Silva SD.
PMID: 25699077
Front Genet. 2015 Feb 04;6:17. doi: 10.3389/fgene.2015.00017. eCollection 2015.

Advances in high-throughput genomic-scanning have expanded the repertory of genetic variations in DNA sequences encoding ErbB tyrosine kinase receptors in humans, including single nucleotide polymorphisms (SNPs), polymorphic repetitive elements, microsatellite variations, small-scale insertions and deletions. The ErbB family members:...

Cite
Alaoui-Jamali MA, Morand GB, da Silva SD. ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics. Front Genet. 2015;6:17doi: 10.3389/fgene.2015.00017.
Alaoui-Jamali, M. A., Morand, G. B., & da Silva, S. D. (2015). ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics. Frontiers in genetics, 617. https://doi.org/10.3389/fgene.2015.00017
Alaoui-Jamali, Moulay A, et al. "ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics." Frontiers in genetics vol. 6 (2015): 17. doi: https://doi.org/10.3389/fgene.2015.00017
Alaoui-Jamali MA, Morand GB, da Silva SD. ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics. Front Genet. 2015 Feb 04;6:17. doi: 10.3389/fgene.2015.00017. eCollection 2015. PMID: 25699077; PMCID: PMC4316710.
Copy Download .nbib Format: NLM
Fascin promotes migration and invasion and is a prognostic marker for oral squamous cell carcinoma.

Oncotarget

Rodrigues PC, Sawazaki-Calone I, Ervolino de Oliveira C, Soares Macedo CC, Dourado MR, Cervigne NK, Miguel MC, Ferreira do Carmo A, Lambert DW, Graner E, Daniela da Silva S, Alaoui-Jamali MA, Paes Leme AF, Salo TA, Coletta RD.
PMID: 29088820
Oncotarget. 2017 Aug 19;8(43):74736-74754. doi: 10.18632/oncotarget.20360. eCollection 2017 Sep 26.

Oral squamous cell carcinoma (OSCC) prognosis is related to clinical stage and histological grade. However, this stratification needs to be refined. We conducted a comparative proteome study in microdissected samples from normal oral mucosa and OSCC to identify biomarkers...

Cite
Rodrigues PC, Sawazaki-Calone I, Ervolino de Oliveira C, et al. Fascin promotes migration and invasion and is a prognostic marker for oral squamous cell carcinoma. Oncotarget. 2017;8(43):74736-74754doi: 10.18632/oncotarget.20360.
Rodrigues, P. C., Sawazaki-Calone, I., Ervolino de Oliveira, C., Soares Macedo, C. C., Dourado, M. R., Cervigne, N. K., Miguel, M. C., Ferreira do Carmo, A., Lambert, D. W., Graner, E., Daniela da Silva, S., Alaoui-Jamali, M. A., Paes Leme, A. F., Salo, T. A., & Coletta, R. D. (2017). Fascin promotes migration and invasion and is a prognostic marker for oral squamous cell carcinoma. Oncotarget, 8(43), 74736-74754. https://doi.org/10.18632/oncotarget.20360
Rodrigues, Priscila Campioni, et al. "Fascin promotes migration and invasion and is a prognostic marker for oral squamous cell carcinoma." Oncotarget vol. 8,43 (2017): 74736-74754. doi: https://doi.org/10.18632/oncotarget.20360
Rodrigues PC, Sawazaki-Calone I, Ervolino de Oliveira C, Soares Macedo CC, Dourado MR, Cervigne NK, Miguel MC, Ferreira do Carmo A, Lambert DW, Graner E, Daniela da Silva S, Alaoui-Jamali MA, Paes Leme AF, Salo TA, Coletta RD. Fascin promotes migration and invasion and is a prognostic marker for oral squamous cell carcinoma. Oncotarget. 2017 Aug 19;8(43):74736-74754. doi: 10.18632/oncotarget.20360. eCollection 2017 Sep 26. PMID: 29088820; PMCID: PMC5650375.
Copy Download .nbib Format: NLM
Showing 13 to 14 of 14 entries